Patents by Inventor Thomas Hengl

Thomas Hengl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CALCIUM HYDROXYAPATITE PARTICLES AND USE THEREOF
    Publication number: 20240074954
    Abstract: The invention relates to calcium hydroxyapatite particles having been sintered at a certain temperature range and which are not treated at a temperature above this range. Furthermore, the present invention relates to an injectable composition comprising such particles and to uses thereof. Surprisingly, it was found that the particles of the invention are superior over calcium hydroxyapatite particles known in the art with respect to bio-stimulation.
    Type: Application
    Filed: January 25, 2022
    Publication date: March 7, 2024
    Inventors: Bartosch NOWAG, Roland STRAGIES, Thomas HENGL, Dean ERICKSON, Tim LIGMAN, Christopher GROPPI
  • Treatment of gynoid lipodystrophy
    Patent number: 11344573
    Abstract: The present invention generally relates to the treatment of gynoid lipodystrophy, and more specifically to the use of calcium (hydroxy)phosphate particles in combination with at least one compound capable of reducing local subcutaneous fat in the treatment of gynoid lipodystrophy.
    Type: Grant
    Filed: October 24, 2017
    Date of Patent: May 31, 2022
    Assignee: MERZ PHARMA GMBH & CO. KGAA
    Inventors: Harry Frank Abst, Rainer Pooth, Martina Kerscher, Thomas Hengl, Birgit Blessmann-Gurk, Sabine Otto
  • TREATMENT OF GYNOID LIPODYSTROPHY
    Publication number: 20190240253
    Abstract: The present invention generally relates to the treatment of gynoid lipodystrophy, and more specifically to the use of calcium (hydroxy)phosphate particles in combination with at least one compound capable of reducing local subcutaneous fat in the treatment of gynoid lipodystrophy.
    Type: Application
    Filed: October 24, 2017
    Publication date: August 8, 2019
    Inventors: Harry Frank ABST, Rainer POOTH, Martina KERSCHER, Thomas HENGL, Birgit BLESSMANN-GURK, Sabine OTTO
  • Topical Application of Vinca Alkaloids for the Treatment of Actinic Keratosis
    Publication number: 20150073008
    Abstract: The present invention provides pharmaceutical compositions comprising a vinca alkaloid of formula (I): or a pharmaceutically acceptable salt (or hydrate) thereof, wherein each of R1, R2, R3, and R4 is as defined and described herein, wherein said formulations are useful for the topical treatment of actinic keratosis.
    Type: Application
    Filed: September 11, 2014
    Publication date: March 12, 2015
    Inventors: Bhushan Hardas, Harry Frank Abts, Thomas Hengl, Kim Schlinzig, Alan Fleischer, Sarah Caley, Jon Parrish, Lutz Franke